NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $504,819 | +14.2% | 4,956 | +13.1% | 0.01% | -77.6% |
| Q2 2023 | $442,087 | +9.7% | 4,381 | 0.0% | 0.06% | 0.0% |
| Q1 2023 | $403,052 | +1.4% | 4,381 | 0.0% | 0.06% | -4.9% |
| Q4 2022 | $397,444 | +19.4% | 4,381 | 0.0% | 0.06% | +10.9% |
| Q3 2022 | $333,000 | -10.0% | 4,381 | 0.0% | 0.06% | -6.8% |
| Q2 2022 | $370,000 | -3.6% | 4,381 | 0.0% | 0.06% | +18.0% |
| Q1 2022 | $384,000 | +14.6% | 4,381 | +14.4% | 0.05% | +13.6% |
| Q4 2021 | $335,000 | +7.0% | 3,831 | 0.0% | 0.04% | -2.2% |
| Q3 2021 | $313,000 | -10.6% | 3,831 | 0.0% | 0.04% | -10.0% |
| Q2 2021 | $350,000 | +28.2% | 3,831 | +20.1% | 0.05% | +13.6% |
| Q1 2021 | $273,000 | -15.2% | 3,191 | -6.3% | 0.04% | -4.3% |
| Q4 2020 | $322,000 | +43.1% | 3,406 | +31.6% | 0.05% | +24.3% |
| Q3 2020 | $225,000 | – | 2,588 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |